Lidocaine Anorectal

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Lidocaine Anorectal
Generic name: LIDOCAINE
Manufacturer: Patrin Pharma, Inc
Product type: HUMAN OTC DRUG
SPL set ID: 456d41fe-8449-4980-9291-d7a3b65a900d
SPL ID: 8baec15b-0d92-4e92-acd5-2c6cfa9083b9
Version: 2
Effective date: 2024-11-13
Source export date: 2026-09-28
Source partition: 7
Source file: https://download.open.fda.gov/drug/label/drug-label-0007-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/bb1af06e95bcf9567b07e56fcf3a03c0cac3c7c82ff89d4c970881174949e5b7/drug-label-0007-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:49:22

Harmonized routes table
Harmonized routes
RECTAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 13 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M015	openfda.application_number
brand name		Lidocaine Anorectal	openfda.brand_name
generic name		LIDOCAINE	openfda.generic_name
manufacturer name		Patrin Pharma, Inc	openfda.manufacturer_name
ndc	package	39328-025-15	openfda.package_ndc
ndc	package	39328-025-30	openfda.package_ndc
ndc	product	39328-025	openfda.product_ndc
ndc11	package	39328002515	derived:openfda.package_ndc
ndc11	package	39328002530	derived:openfda.package_ndc
rxcui		1366789	openfda.rxcui
spl id		8baec15b-0d92-4e92-acd5-2c6cfa9083b9	id
spl set id		456d41fe-8449-4980-9291-d7a3b65a900d	set_id
unii		98PI200987	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings When using this product Avoid contact with eyes Do not exceed recommended dosage unless directed by a doctor Stop use and ask a doctor if Rectal bleeding occurs Condition worsens or does not improve within 7 days Allergic reaction occurs Redness, irritation, swelling, pain or other symptoms begin or increase Symptoms clear up and return within a few days Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.